A citation-based method for searching scientific literature

Harvey D White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y Davies, Andrzej Budaj, Robert A Harrington, P Gabriel Steg, Diego Ardissino, Paul W Armstrong, Alvaro Avezum, Philip E Aylward, Alfonso Bryce, Hong Chen, Ming-Fong Chen, Ramon Corbalan, Anthony J Dalby, Nicolas Danchin, Robbert J De Winter, Stefan Denchev, Rafael Diaz, Moses Elisaf, Marcus D Flather, Assen R Goudev, Christopher B Granger, Liliana Grinfeld, Judith S Hochman, Steen Husted, Hyo-Soo Kim, Wolfgang Koenig, Ales Linhart, Eva Lonn, José López-Sendón, Athanasios J Manolis, Emile R Mohler, José C Nicolau, Prem Pais, Alexander Parkhomenko, Terje R Pedersen, Daniel Pella, Marco A Ramos-Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Peter Smith, Piyamitr Sritara, Henk P Swart, Rody G Sy, Tamio Teramoto, Hung-Fat Tse, David Watson, W Douglas Weaver, Robert Weiss, Margus Viigimaa, Dragos Vinereanu, Junren Zhu, Christopher P Cannon, Lars Wallentin. N Engl J Med 2014
Times Cited: 358







List of co-cited articles
832 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, P Gabriel Steg, Judith S Hochman, Christoph Bode, Aldo P Maggioni, KyungAh Im,[...]. JAMA 2014
292
62

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
49

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Stephen J Nicholls, John J P Kastelein, Gregory G Schwartz, Dianna Bash, Robert S Rosenson, Matthew A Cavender, Danielle M Brennan, Wolfgang Koenig, J Wouter Jukema, Vijay Nambi,[...]. JAMA 2014
201
31

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
872
30

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
550
29

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
Alexander Thompson, Pei Gao, Lia Orfei, Sarah Watson, Emanuele Di Angelantonio, Stephen Kaptoge, Christie Ballantyne, Christopher P Cannon, Michael Criqui, Mary Cushman,[...]. Lancet 2010
466
25

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
Michelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, Philip E Aylward, Marc P Bonaca, Andrzej Budaj, Richard Y Davies, Mikael Dellborg, Keith A A Fox, Jorge Antonio T Gutierrez,[...]. JAMA 2016
147
24

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
479
22

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
Robert L Wilensky, Yi Shi, Emile R Mohler, Damir Hamamdzic, Mark E Burgert, Jun Li, Anthony Postle, Robert S Fenning, James G Bollinger, Bryan E Hoffman,[...]. Nat Med 2008
286
18

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
419
17

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
16

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
16

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
644
14


Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Claes Held, Harvey D White, Ralph A H Stewart, Andrzej Budaj, Christopher P Cannon, Judith S Hochman, Wolfgang Koenig, Agneta Siegbahn, Philippe Gabriel Steg, Joseph Soffer,[...]. J Am Heart Assoc 2017
108
14

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
13


Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
Kaivan Vaidya, Clare Arnott, Gonzalo J Martínez, Bernard Ng, Samuel McCormack, David R Sullivan, David S Celermajer, Sanjay Patel. JACC Cardiovasc Imaging 2018
121
13


Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
12

C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
11

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
Patrick W Serruys, Héctor M García-García, Pawel Buszman, Paul Erne, Stefan Verheye, Michael Aschermann, Henrikus Duckers, Oyvind Bleie, Dariusz Dudek, Hans Erik Bøtker,[...]. Circulation 2008
416
11

Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
Jean-Claude Tardif, Jean-François Tanguay, Scott R Wright, Valérie Duchatelle, Thibaut Petroni, Jean C Grégoire, Reda Ibrahim, Therese M Heinonen, Stephen Robb, Olivier F Bertrand,[...]. J Am Coll Cardiol 2013
120
11

Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
Gonzalo J Martínez, Stacy Robertson, Jennifer Barraclough, Qiong Xia, Ziad Mallat, Christina Bursill, David S Celermajer, Sanjay Patel. J Am Heart Assoc 2015
161
11

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
Jean-Claude Tardif, John J V McMurray, Eric Klug, Robert Small, Jennifer Schumi, Jasmine Choi, Jim Cooper, Robert Scott, Eldrin F Lewis, Philippe L L'Allier,[...]. Lancet 2008
142
11

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
11

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
191
10

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
Harvey White, Claes Held, Ralph Stewart, David Watson, Robert Harrington, Andrzej Budaj, Ph Gabriel Steg, Christopher P Cannon, Susan Krug-Gourley, Janet Wittes,[...]. Am Heart J 2010
99
10

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
Lars Wallentin, Claes Held, Paul W Armstrong, Christopher P Cannon, Richard Y Davies, Christopher B Granger, Emil Hagström, Robert A Harrington, Judith S Hochman, Wolfgang Koenig,[...]. J Am Heart Assoc 2016
39
25


Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.
Robert S Rosenson, Colin Hislop, Michael Elliott, Yuri Stasiv, Michael Goulder, David Waters. J Am Coll Cardiol 2010
63
14


The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
Allison C Morton, Alexander M K Rothman, John P Greenwood, Julian Gunn, Alex Chase, Bernard Clarke, Alistair S Hall, Keith Fox, Claire Foley, Winston Banya,[...]. Eur Heart J 2015
174
9

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Stephen Kaptoge, Emanuele Di Angelantonio, Gordon Lowe, Mark B Pepys, Simon G Thompson, Rory Collins, John Danesh. Lancet 2010
9

PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
Juan P Casas, Ewa Ninio, Andrie Panayiotou, Jutta Palmen, Jackie A Cooper, Sally L Ricketts, Reecha Sofat, Andrew N Nicolaides, James P Corsetti, F Gerry R Fowkes,[...]. Circulation 2010
88
10

Effects of torcetrapib in patients at high risk for coronary events.
Philip J Barter, Mark Caulfield, Mats Eriksson, Scott M Grundy, John J P Kastelein, Michel Komajda, Jose Lopez-Sendon, Lori Mosca, Jean-Claude Tardif, David D Waters,[...]. N Engl J Med 2007
9

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
9

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
Nadeem Sarwar, Adam S Butterworth, Daniel F Freitag, John Gregson, Peter Willeit, Donal N Gorman, Pei Gao, Danish Saleheen, Augusto Rendon, Christopher P Nelson,[...]. Lancet 2012
507
9

Lipoprotein-associated phospholipase A2: The story continues.
Fubao Huang, Kai Wang, Jianhua Shen. Med Res Rev 2020
42
21

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Paul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, Jacques Genest, Antonio M Gotto, John Jp Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G Macfadyen,[...]. Lancet 2009
732
9

A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.
Iona Y Millwood, Derrick A Bennett, Robin G Walters, Robert Clarke, Dawn Waterworth, Toby Johnson, Yiping Chen, Ling Yang, Yu Guo, Zheng Bian,[...]. Int J Epidemiol 2016
22
36



Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
David C Tong, Stephen Quinn, Arthur Nasis, Chin Hiew, Philip Roberts-Thomson, Heath Adams, Rumes Sriamareswaran, Nay M Htun, William Wilson, Dion Stub,[...]. Circulation 2020
104
8


Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Steven E Nissen, E Murat Tuzcu, Paul Schoenhagen, Tim Crowe, William J Sasiela, John Tsai, John Orazem, Raymond D Magorien, Charles O'Shaughnessy, Peter Ganz. N Engl J Med 2005
7


Effects of dalcetrapib in patients with a recent acute coronary syndrome.
Gregory G Schwartz, Anders G Olsson, Markus Abt, Christie M Ballantyne, Philip J Barter, Jochen Brumm, Bernard R Chaitman, Ingar M Holme, David Kallend, Lawrence A Leiter,[...]. N Engl J Med 2012
7

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
Stephen J Nicholls, Rishi Puri, Todd Anderson, Christie M Ballantyne, Leslie Cho, John J P Kastelein, Wolfgang Koenig, Ransi Somaratne, Helina Kassahun, Jingyuan Yang,[...]. JAMA 2016
526
7

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.